Also, the STAT3 inhibitor, BP-1-102, can reduce the expression of inflammatory factors and MMPs bound to NF-kB by inhibiting the activation of the JAK/STAT3/NF-kB pathway, and then restore the vascular wall elastin to reduce blood pressure, thereby treating aneurysms in mice [88]. This evidence concerns the gene NFKB1 and aneurysm.